Join us for the Design Thinking Executive Education program taking place 17 – 20 June 2014. This program distills design thinking into a clear process that will help you decrease the risk and cost of your projects by framing the challenges correctly so that innovation is maximized. Program participants will learn how to identify a challenge/opportunity and then how the steps of design thinking can be applied to it. They’ll walk away from the program with their own project plan to be applied to their specific opportunity.
Join us on May 14th at 9:00am Pacific Time for our next webinar event as Academic Director, Robert Sutton, discusses how to scale innovation without screwing up.
PCORI App Challenge
The Patient-Centered Outcomes Research Institute (PCORI) was authorized in 2010 by the Patient Protection and Affordable Care Act to help patients make better-informed health and health care decisions, and improve healthcare delivery and outcomes, by producing and promoting high-integrity, evidence-based information.
The Successes and Challengs of Open Source Biopharmaceutical Innovation
Increasingly, open-source–based alliances seek to provide broad access to data, research-based tools, preclinical samples and downstream compounds. The challenge is how to create value from open-source biopharmaceutical innovation. This value creation may occur via transparency and usage of data across the biopharmaceutical value chain as stakeholders move dynamically between open source and open innovation.
It is the author’s opinion that the assessment of when and how value creation will occur, through open-source biopharmaceutical innovation, is paramount. The key is to determine the metrics of value creation and the necessary technological, educational and legal frameworks to support the downstream outcomes of now big data-based open-source initiatives. The continued focus on the early-stage value creation is not advisable. Instead, it would be more advisable to adopt an approach where stakeholders transform open-source initiatives into open-source discovery, crowdsourcing and open product development partnerships on the same platform.
Read More: http://informahealthcare.com/doi/abs/10.1517/17460441.2014.905539?af=R
Encouraging Pharmaceutical Innovation in Middle-Income Countries
The opportunity to develop innovative activities from basic research through to clinical development varies from country to country. To be successful, a jigsaw of policies is needed, including a coordinated industrial and health policy, strong IP protection and an environment that encourages partnerships among the different stakeholders.
Innovation Capacity Development
Business Innovations at the Base of the Pyramid: A Breakout Session
The 4.5 billion people in the world at "the base of the pyramid" (who live on $5 per day or less) represent a $15 trillion economy. Panelists describe their ventures at the base of the pyramid and respond to a range of questions from attendees.
Globalization of Innovation and R&D: A Breakout Session
Panelists describe how their organizations benefit from a global approach to innovation, and how they cope with innovation-related challenges.
Using Open Innovation To Find New Medicines: The AstraZeneca Case Example:
The new AstraZeneca openinnovation website is a portal for any investigator to submit proposals across a range of drug discovery and development activities. For example, the Clinical Compound Bank and Pharmacology Toolbox provide information on a number of AstraZeneca compounds, including clinical compounds in the AstraZeneca early drug pipeline, and an easy to use process for investigators to submit proposals to access the compounds for clinical and/or preclinical investigation.
Big Pharma Turns to Enterprise Social Networking
Read more how ESN has enabled agility at three stages of the drug development lifecycle: designing; manufacturing; and selling.
Big data: The next frontier for innovation, competition, and productivity
The amount of data in our world has been exploding, and analyzing large data sets—so-called big data—will become a key basis of competition, underpinning new waves of productivity growth, innovation, and consumer surplus, according to research by MGI and McKinsey's Business Technology Office.